A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Stopped Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.

Conditions

• Anemia

Interventions

• DRUG: Peginesatide

Sponsor

Takeda

Collaborators

• [object Object]